Evidence map›Paper›PMID 41264065›Full record

ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2026

Demographic and health impacts of women's bodily autonomy: switching prescription requirements for emergency contraceptives.

Fabian Grünwald, Tom Stargardt

Abstract read
In one paragraph

Article in The European journal of health economics : HEPAC : health economics in prevention and care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fabian GrünwaldHamburg Center for Health Economics, University of Hamburg, Hamburg, Germany. Fabian.gruenwald@uni-hamburg.de.ORCID http://orcid.org/0000-0002-1889-8029
Tom StargardtHamburg Center for Health Economics, University of Hamburg, Hamburg, Germany.ORCID http://orcid.org/0000-0003-3954-0955

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past decades, most European countries switched emergency contraceptive availability from prescription to over-the-counter (OTC) status. However, the effect of OTC switches on emergency and regular contraceptive use, on demographic indicators (birth rate, abortion rate) and health outcomes (sexually transmitted diseases) varies depending on the study setting. Only Poland switched emergency contraceptives back to prescription (Rx) status after previously loosening restrictions and causal analyses of an Rx switch are lacking entirely. We employ multiple (staggered/synthetic) difference-in-differences models to evaluate the effect of (a) an OTC switch, exploiting variation in the timing of the OTC switch among several European countries and (b) a Rx switch at the example of Poland. We find that the use of emergency contraceptives increased (decreased) after OTC (Rx) switches. The use of regular hormonal contraceptives, the rate of births and abortions and the incidence of various sexually transmitted diseases remained essentially unaffected or - if found - effects did not withstand robustness checks. Our results suggest that increased use of emergency contraceptives due to liberalized over-the-counter access may be reversed by a return to prescription bound access.

Indexed as

Contraception, PostcoitalContraceptives, PostcoitalNonprescription DrugsPrescription DrugsAbortion, InducedAdolescentAdultBirth RateEuropeFemaleHumansPolandPregnancySexually Transmitted DiseasesYoung AdultContraceptives, PostcoitalNonprescription DrugsPrescription DrugsAbortionsBirth rateEmergency contraceptionOTC switchSexually transmitted diseases

Identifiers

PMID41264065
PMCPMC13451442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.